This article has been cited by
1
F. Meiss,R. Zeiser
.2014;201()405
[DOI]
2Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Mark A. Feitelson,Alla Arzumanyan,Rob J. Kulathinal,Stacy W. Blain,Randall F. Holcombe,Jamal Mahajna,Maria Marino,Maria L. Martinez-Chantar,Roman Nawroth,Isidro Sanchez-Garcia,Dipali Sharma,Neeraj K. Saxena,Neetu Singh,Panagiotis J. Vlachostergios,Shanchun Guo,Kanya Honoki,Hiromasa Fujii,Alexandros G. Georgakilas,Alan Bilsland,Amedeo Amedei,Elena Niccolai,Amr Amin,S. Salman Ashraf,Chandra S. Boosani,Gunjan Guha,Maria Rosa Ciriolo,Katia Aquilano,Sophie Chen,Sulma I. Mohammed,Asfar S. Azmi,Dipita Bhakta,Dorota Halicka,W. Nicol Keith,Somaira Nowsheen
Seminars in Cancer Biology.2015;35()S25
[DOI]
3Pediatric adrenocortical tumors: diagnosis, management and advancements in the understanding of the genetic basis and therapeutic implications
Sonir R Antonini,Letícia F Leal,Marcelo M Cavalcanti
Expert Review of Endocrinology & Metabolism.2014;9(5)445
[DOI]
4Genomic landscape of gastric cancer: molecular classification and potential targets
Jiawei Guo,Weiwei Yu,Hui Su,Xiufeng Pang
Science China Life Sciences.2017;60(2)126
[DOI]
5Treatment of Basal Cell Carcinoma Via Binary Ethosomes of Vismodegib: In Vitro and In Vivo Studies
Amr Gamal F,Ossama M. Sayed,Fatma I. Abo El-Ela,Rasha M. Kharshoum,Heba F. Salem
AAPS PharmSciTech.2020;21(2)126
[DOI]
6CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway
Ju Chen,Haining Lv,Jinping Hu,Ming Ji,Nina Xue,Chao Li,Shuanggang Ma,Qin Zhou,Bin Lin,Yan Li,Shishan Yu,Xiaoguang Chen
Cancer Letters.2016;381(2)391
[DOI]
7Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer
Hideya Onishi,Akio Yamasaki,Makoto Kawamoto,Akira Imaizumi,Mitsuo Katano
Cancer Letters.2016;371(2)143
[DOI]
8Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
Daniel V.T. Catenacci,Melissa R. Junttila,Theodore Karrison,Nathan Bahary,Margit N. Horiba,Sreenivasa R. Nattam,Robert Marsh,James Wallace,Mark Kozloff,Lakshmi Rajdev,Deirdre Cohen,James Wade,Bethany Sleckman,Heinz-Josef Lenz,Patrick Stiff,Pankaj Kumar,Peng Xu,Les Henderson,Naoko Takebe,Ravi Salgia,Xi Wang,Walter M. Stadler,Frederic J. de Sauvage,Hedy L. Kindler
Journal of Clinical Oncology.2015;33(36)4284
[DOI]
9Targeting Hedgehog signaling pathway: Paving the road for cancer therapy
Ali Salaritabar,Ioana Berindan-Neagoe,Behrad Darvish,Farzaneh Hadjiakhoondi,Azadeh Manayi,Kasi Pandima Devi,Davide Barreca,Ilkay Erdogan Orhan,Ipek Süntar,Ammad Ahmad Farooqi,Diana Gulei,Seyed Fazel Nabavi,Antoni Sureda,Maria Daglia,Ahmad R. Dehpour,Seyed Mohammad Nabavi,Samira Shirooie
Pharmacological Research.2019;141(36)466
[DOI]
10Targeting the cross-talk between the hedgehog and NF-?B signaling pathways in multiple myeloma
Ke Cai,Wenxiu Na,Mengjie Guo,Ruirong Xu,Xinfeng Wang,Yi Qin,Yan Wu,Jie Jiang,Hongming Huang
Leukemia & Lymphoma.2019;60(3)772
[DOI]
11Nonmelanoma Skin Cancers
Giovanni Nicoletti,Marco Mario Tresoldi,Alberto Malovini,Borelli Francesco,Angela Faga
Plastic and Reconstructive Surgery - Global Open.2020;8(4)e2683
[DOI]
12Defining the Role of GLI/Hedgehog Signaling in Chemoresistance: Implications in Therapeutic Approaches
Jian Yi Chai,Vaisnevee Sugumar,Ahmed F. Alshanon,Won Fen Wong,Shin Yee Fung,Chung Yeng Looi
Cancers.2021;13(19)4746
[DOI]
13Molecular modeling study on resistance of WT/D473H SMO to antagonists LDE-225 and LEQ-506
Jing Tu,Jiao Jiao Li,Li Ting Song,Hong Lin Zhai,Juan Wang,Xiao Yun Zhang
Pharmacological Research.2018;129(19)491
[DOI]
14Molecular modeling study on resistance of WT/D473H SMO to antagonists LDE-225 and LEQ-506
Sofía L. Acebedo,Javier A. Ramírez
Pharmacological Research.2021;129(19)1
[DOI]
15Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) – gene transcription, cell cycle regulation, metabolism and intercellular communication
Håkon Reikvam,Michelle Hauge,Annette K Brenner,Kimberley Joanne Hatfield,Øystein Bruserud
Expert Review of Hematology.2015;8(3)299
[DOI]
16Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) – gene transcription, cell cycle regulation, metabolism and intercellular communication
Hui-Yi Xue,Reina Bendayan,Ho-Lun Wong
Expert Review of Hematology.2020;8(3)121
[DOI]
17Hepatotoxicity Associated With Vismodegib
Prabhjot S Bedi,Manoj P Rai,Nishant Tageja,Heather Laird-Fick
BMJ Case Reports.2018;8(3)bcr-2017-222969
[DOI]
18Ocular tumors: Triumphs, challenges and controversies
Ralph C. Eagle
Saudi Journal of Ophthalmology.2013;27(3)129
[DOI]
19Synthesis and Investigation of S-Substituted 2-Mercaptobenzoimidazoles as Inhibitors of Hedgehog Signaling
Simone Gräßle,Steven Susanto,Sonja Sievers,Emel Tavsan,Martin Nieger,Nicole Jung,Stefan Bräse
ACS Medicinal Chemistry Letters.2017;8(9)931
[DOI]
20Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates
Fatma E. El-Khouly,Dannis G. van Vuurden,Thom Stroink,Esther Hulleman,Gertjan J. L. Kaspers,N. Harry Hendrikse,Sophie E. M. Veldhuijzen van Zanten
Frontiers in Oncology.2017;7(9)931
[DOI]
21Fatty acid 2-hydroxylation inhibits tumor growth and increases sensitivity to cisplatin in gastric cancer
Yizhou Yao,Xiaoqin Yang,Liang Sun,Shishuo Sun,Xiaoheng Huang,Diyuan Zhou,Tingting Li,Wei Zhang,Nada A. Abumrad,Xinguo Zhu,Songbing He,Xiong Su
EBioMedicine.2019;41(9)256
[DOI]
22Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells
S-Y Ju,C-YF Huang,W-C Huang,Y Su
Cell Death & Disease.2015;6(7)e1801
[DOI]
23Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells
Frank Meiss,Hana Andrlová,Robert Zeiser
Cell Death & Disease.2018;211(7)125
[DOI]
24Sonic Hedgehog Signaling Is Active in Human Adrenal Cortex Development and Deregulated in Adrenocortical Tumors
Débora C. Gomes,Letícia F. Leal,Livia M. Mermejo,Carlos A. Scrideli,Carlos E. Martinelli,Maria C. B. V. Fragoso,Ana C. Latronico,Luis G. Tone,Silvio Tucci,Jose A. Yunes,Izilda A. Cardinalli,Maria J. Mastellaro,Silvia R. Brandalise,Fernando Ramalho,Ayrton C. Moreira,Leandra N. Ramalho,Margaret de Castro,Sonir R. R. Antonini
The Journal of Clinical Endocrinology & Metabolism.2014;99(7)E1209
[DOI]
25The hedgehog pathway in nonalcoholic fatty liver disease
Mariana Verdelho Machado,Anna Mae Diehl
Critical Reviews in Biochemistry and Molecular Biology.2018;53(3)264
[DOI]
26The hedgehog pathway in nonalcoholic fatty liver disease
Youssef W. Naguib,Zhengrong Cui
Critical Reviews in Biochemistry and Molecular Biology.2014;811(3)207
[DOI]
27MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling
Jeongeun Hyun,Youngmi Jung
World Journal of Gastroenterology.2016;22(29)6652
[DOI]
28PEG-b-poly (carbonate)-derived nanocarrier platform with pH-responsive properties for pancreatic cancer combination therapy
Priyanka Ray,Matthew Confeld,Pawel Borowicz,Tao Wang,Sanku Mallik,Mohiuddin Quadir
Colloids and Surfaces B: Biointerfaces.2019;174(29)126
[DOI]
29Metformin influences drug sensitivity in pancreatic cancer cells
Saverio Candido,Stephen L. Abrams,Linda Steelman,Kvin Lertpiriyapong,Alberto M. Martelli,Lucio Cocco,Stefano Ratti,Matilde Y. Follo,Ramiro M. Murata,Pedro L. Rosalen,Paolo Lombardi,Giuseppe Montalto,Melchiorre Cervello,Agnieszka Gizak,Dariusz Rakus,Pann-Gill Suh,Massimo Libra,James A. McCubrey
Advances in Biological Regulation.2018;68(29)13
[DOI]
30The Influence of Omeprazole on the Dissolution Processes of pH-Dependent Magnetic Tablets Assessed by Pharmacomagnetography
Guilherme A. Soares,Deivid W. Pires,Leonardo A. Pinto,Gustavo S. Rodrigues,André G. Prospero,Gabriel G. A. Biasotti,Gabriela N. Bittencourt,Erick G. Stoppa,Luciana A. Corá,Ricardo B. Oliveira,José R. A. Miranda
Pharmaceutics.2021;13(8)1274
[DOI]
31Cancer stem cell targeting: Are we there yet?
Yuchae Jung,Woo-Young Kim
Archives of Pharmacal Research.2015;38(3)414
[DOI]
32Pushing tumor cells towards a malignant phenotype: Stimuli from the microenvironment, intercellular communications and alternative roads
Fabrizio Marcucci,Matteo Bellone,Carmelo Antonio Caserta,Angelo Corti
International Journal of Cancer.2014;135(6)1265
[DOI]
33Sites of Basal Cell Carcinomas and Head and Neck Congenital Clefts
Giovanni Nicoletti,Federica Brenta,Alberto Malovini,Omar Jaber,Angela Faga
Plastic and Reconstructive Surgery Global Open.2014;2(6)e164
[DOI]
34Hedgehog-mesenchyme gene signature identifies bi-modal prognosis in luminal and basal breast cancer sub-types
Wandaliz Torres-García,Maribella Domenech
Molecular BioSystems.2017;13(12)2615
[DOI]
35Hedgehog pathway overexpression in pancreatic cancer is abrogated by new-generation taxoid SB-T-1216
B Mohelnikova-Duchonova,M Kocik,B Duchonova,V Brynychova,M Oliverius,J Hlavsa,E Honsova,J Mazanec,Z Kala,I Ojima,D J Hughes,J E Doherty,H A Murray,M A Crockard,R Lemstrova,P Soucek
The Pharmacogenomics Journal.2017;17(5)452
[DOI]
36Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
Elisabetta Rovida,Barbara Stecca
Seminars in Cancer Biology.2015;35(5)154
[DOI]
37PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAP
Souheyla Bensalma,Soumaya Turpault,Annie-Claire Balandre,Madryssa De Boisvilliers,Afsaneh Gaillard,Corinne Chadéneau,Jean-Marc Muller
Cancers.2019;11(1)123
[DOI]
38Control of basal cell carcinoma via positively charged ethosomes of Vismodegib: In vitro and in vivo studies
F. Amr Gamal,Rasha M. Kharshoum,Ossama M. Sayed,Fatma I. Abo El-Ela,Heba F. Salem
Journal of Drug Delivery Science and Technology.2020;56(1)101556
[DOI]
39Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells
Timothy L. Fitzgerald,Kvin Lertpiriyapong,Lucio Cocco,Alberto M. Martelli,Massimo Libra,Saverio Candido,Giuseppe Montalto,Melchiorre Cervello,Linda Steelman,Stephen L. Abrams,James A. McCubrey
Advances in Biological Regulation.2015;59(1)65
[DOI]
40Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells
Timothy L. Fitzgerald,Kvin Lertpiriyapong,Lucio Cocco,Alberto M. Martelli,Massimo Libra,Saverio Candido,Giuseppe Montalto,Melchiorre Cervello,Linda Steelman,Stephen L. Abrams,James A. McCubrey
Advances in Biological Regulation.2017;59(1)393
[DOI]
41Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment
Suleyman Vural,Richard Simon,Julia Krushkal
Human Genomics.2018;12(1)393
[DOI]
42Hedgehog Pathway Inhibitors against Tumor Microenvironment
Silpa Gampala,Jer-Yen Yang
Cells.2021;10(11)3135
[DOI]
43Mann med stort hode, lærevansker og multiple basalcellekarsinomer
Charlotte von der Lippe,Ingrid Roscher,Hilde Nordgarden,Cecilie Rustad,Selma Mujezinovic Larsen,Even Mjøen,Åse Bratland
Tidsskrift for Den norske legeforening.2014;134(11)1151
[DOI]
44NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer
Angela N. Flores,Niamh McDermott,Armelle Meunier,Laure Marignol
Nature Reviews Urology.2014;11(9)499
[DOI]
45Mature salivary gland rests within sonic hedgehog–positive medulloblastoma: case report and insights into the molecular genetics and embryopathology of ectopic intracranial salivary gland analogs
Berje Shammassian,Sunil Manjila,Efrem Cox,Kaine Onwuzulike,Dehua Wang,Mark Rodgers,Duncan Stearns,Warren R. Selman
Journal of Neurosurgery: Pediatrics.2016;18(6)708
[DOI]
46Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma
Lei Wang,Joy Q. Jin,Yong Zhou,Ziqiang Tian,David M. Jablons,Biao He
Oncotarget.2018;9(1)853
[DOI]
47Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma
Nagavalli Somasundaram,Sock Hoai Chan,Richard Quek,Joanne Ngeow
Oncotarget.2019;9(1)609
[DOI]
48MicroRNA-1271 inhibits proliferation and promotes apoptosis of multiple myeloma cells through inhibiting smoothened-mediated Hedgehog signaling pathway
Zhengwei Xu,Chen Huang,Dingjun Hao
Oncology Reports.2017;37(2)1261
[DOI]
49Sonidegib: A Review in Locally Advanced Basal Cell Carcinoma
Celeste B. Burness,Lesley J. Scott
Targeted Oncology.2016;11(2)239
[DOI]
50Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44+/Musashi-1+ gastric cancer stem cells
Min Xu,Aihua Gong,Hongqiong Yang,Suraj K. George,Zhijun Jiao,Hongmei Huang,Xiaomeng Jiang,Youli Zhang
Cancer Letters.2015;369(1)124
[DOI]
51An overview of current and future treatment options for chondrosarcoma
Chen-Ming Su,Yi-Chin Fong,Chih-Hsin Tang
Expert Opinion on Orphan Drugs.2014;2(3)217
[DOI]
52Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma –induced liver fibrosis
Abeer A. Elhenawy,Rehab H. Ashour,Nairmen Nabih,Naglaa M. Shalaby,Nirmeen Megahed
Parasitology International.2017;66(5)545
[DOI]
53An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis
Yanping Li,Shiyun Pu,Qinhui Liu,Rui Li,Jinhang Zhang,Tong Wu,Lei Chen,Hong Li,Xuping Yang,Min Zou,Jia Xiao,Wen Xie,Jinhan He
Journal of Controlled Release.2019;303(5)77
[DOI]
54Dual SMO/BRAF Inhibition by Flavonolignans from Silybum marianum
Antonia Diukendjieva,Maya M. Zaharieva,Mattia Mori,Petko Alov,Ivanka Tsakovska,Tania Pencheva,Hristo Najdenski,Vladimír Kren,Chiara Felici,Francesca Bufalieri,Lucia Di Marcotullio,Bruno Botta,Maurizio Botta,Ilza Pajeva
Antioxidants.2020;9(5)384
[DOI]
  Feedback 
  Subscribe